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Abstract
Background: Limited data are available describing the clinical presentation and risk factors for admission to the intensive
care unit for children with 2009 H1N1 infection.
Methods: We conducted a retrospective chart review of all hospitalized children with 2009 influenza A (H1N1) and 2008–09
seasonal influenza at The Children’s Hospital, Denver, Colorado.
Results: Of the 307 children identified with 2009 H1N1 infections, the median age was 6 years, 61% were male, and 66% had
underlying medical conditions. Eighty children (26%) were admitted to the ICU. Thirty-two (40%) of the ICU patients
required intubation and 17 (53%) of the intubated patients developed acute respiratory distress syndrome (ARDS). Four
patients required extracorporeal membrane oxygenation. Eight (3%) of the hospitalized children died. Admission to the ICU
was significantly associated with older age and underlying neurological condition. Compared to the 90 children admitted
during the 2008–09 season, children admitted with 2009 H1N1 influenza were significantly older, had a shorter length of
hospitalization, more use of antivirals, and a higher incidence of ARDS.
Conclusions: Compared to the 2008–09 season, hospitalized children with 2009 H1N1 influenza were much older and had
more severe respiratory disease. Among children hospitalized with 2009 H1N1 influenza, risk factors for admission to the
ICU included older age and having an underlying neurological condition. Children under the age of 2 hospitalized with 2009
H1N1 influenza were significantly less likely to require ICU care compared to older hospitalized children.
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Introduction
In June 2009, the World Health Organization declared that the
spread of the 2009 influenza A (H1N1) virus had reached
pandemic levels [1]. Certainly the numbers affected and the media
coverage were different for 2009 H1N1 than for a typical influenza
season, but whether 2009 H1N1 was different clinically from
seasonal influenza is unclear.
In this study, we present our experience with children admitted
to a tertiary care children’s hospital with 2009 H1N1 infection and
provide a comparison to the prior influenza season in order to
provide a context for our findings. Our primary goals were to
describe the demographic characteristics, clinical features, labora-
tory findings, and outcomes of consecutively, hospitalized children
with H1N1 infection and to compare children admitted to the
Intensive Care Unit (ICU) with those admitted to the pediatric
floor. Our secondary goal was to compare children hospitalized
with 2009 H1N1 to those admitted with 2008–09 seasonal
influenza.
Methods
Patients and setting
We conducted a retrospective chart review of hospitalized
patients at The Children’s Hospital (TCH), Denver, Colorado, an
academic, tertiary-care, 314-bed hospital serving Colorado and
the surrounding states. TCH’s primary catchment population is
the Denver metro area, which has a population of approximately
2.5 million people. The hospital has approximately 13,000
inpatient admissions and 117,000 emergency room/urgent care
visits a year.
For the 2009 H1N1 cohort, eligible patients included all
children who were admitted to the pediatric floor or to the
intensive care unit who had a respiratory specimen positive for the
2009 influenza A H1N1 virus from May 1, 2009 to November 30,
2009. For seasonal influenza patients, all patients admitted with a
positive respiratory specimen for seasonal influenza A or B from
December 2008 to May 2009 were included in the cohort. A list of
patients was generated by identifying respiratory samples which
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antibody (DFA) or real-time reverse transcriptase-polymerase-
chain-reaction (RT-PCR). Samples that were positive by IA or
DFA, but negative by RT-PCR were excluded. Respiratory
specimens consisted primarily of nasopharyngeal washes.
IA was performed using BinaxNOWH Influenza A and B kits
(Binax, Inc. Scarborough, Maine,USA). Respiratory specimens
were extracted using viral RNA kits on a BioRobot EZ1 extractor
(Qiagen, Valencia, CA) per manufacturer instructions and tested
in the clinical laboratory by multipex PCR for 12 respiratory
viruses and subtypes by xTag H Respiratory Virus Panel, RVP
(Luminex Molecular Diagnostics, Toronto CN). Previously
published reports[2], in addition to our clinical laboratory’s
experience (unpublished data), have shown that specimens
identified as nontypeable influenza A using this assay were
uniformly confirmed to be the 2009 pandemic influenza A (H1N1)
strain using the published CDC assay. Based on these results,
specimens were considered to be 2009 H1N1 positive if
determined to be influenza A and non typeable by PCR.
Clinical, laboratory, and demographic information was obtained
by chart review by physicians in the Departments of Critical Care
and Infectious Diseases. The day of admission was considered
hospital day 0. Obesity was defined as body mass index above the
95
th percentile for age and sex [3]. Bacterial infections were defined
as any positive culture from a normally sterile site. A diagnosis of
asthma was based on patient reportof medical history.Hypoxia was
defined by use of oxygen during the hospitalization. Acute
respiratory distress syndrome was defined as acute onset, non
cardiogenic edema with bilateral pulmonary infiltrates on chest
radiograph and a ratio of partial pressure of oxygen inarterial blood
(PaO2) to fraction concentration of oxygen in inspired air (FiO2)o f
less than or equal to 200 or requiring high peak end expiratory
pressure to maintain inspired oxygen levels at non toxic levels [4].
The criteria for admission to the hospital and the ICU during the
2008–09 and 2009 H1N1 season remained the same.
The protocol and standardized data collection form were
approved by the Colorado Multiple Institutional Review Board.
Waiver of informed consent was approved for retrospective chart
review of study participants. Study data were collected and
managed using REDCap electronic data capture tools hosted at
The University of Colorado [5].
Statistical analysis
We evaluated the characteristics of the children who had 2009
H1N1 influenza admitted to the pediatric floor and the ICU and
compared them to identify potential risk factors for more severe
disease. We also compared children hospitalized with 2009 H1N1
to those who were admitted with 2008–09 seasonal influenza to
identify potentially unique clinical characteristics of 2009 H1N1.
For categorical variables, the percentages of patients in each
category were calculated. Wilcoxon rank-sum test was used for
continuous variables and Fisher’s exact test or the chi-square test for
dichotomous variables. Percentages of expected characteristics of all
hospitalized patients based on published population rates [6] were
compared to observed characteristics using the chi square statistic.
Factors that had a significant association (p,0.05) with ICU
admission were put into a full model for multiple logistic regression
analyses. A backward selection method was performed for model
fitting and predictors with the highest p-value were taken out from
the model one at a time until achievement of the most parsimonious
model. Both p-value of individual effect and Akaike Information
Criterion were used to assessmodel fitting. Allanalysesforthisstudy
were performed with SAS software, version 9.2.
Results
2009 H1N1 Demographics
From May 1 to November 30, 2009, 307 children with 2009
H1N1 influenza infection were hospitalized of which 80 (26%)
were admitted to the ICU (Figure 1). The demographics of
children admitted with 2009 H1N1 influenza are shown in
Table 1. The median age of ICU patients was 6.7 years and of
floor patients was 5.7 years (p=0.02). The age grouping with the
largest number of children admitted to the ICU was 4–5 years of
age, whereas the largest age group of children admitted to the floor
was less than 2 years of age (Figure 2).
Figure 1. Children hospitalized with 2009 H1N1 influenza infection by week of admission.
doi:10.1371/journal.pone.0015173.g001
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medical condition, of which asthma (26%), neurological disorders
(24%), and obesity (19%) were the most common. Thirty (38%)
children hospitalized in the ICU had a neurological condition. In
contrast, 44 (20%) children admitted to the floor had an
underlying neurological condition (p=0.002).
2009 H1N1 Clinical Features and Hospital Course
The presenting signs and symptoms and laboratory values of
hospitalized children with 2009 H1N1 are presented in Table 2.
Seizures (p,0.001), mental status changes (p,0.001), decreased
breath sounds (p=0.006), and hypoxia (p=0.007) were signifi-
cantly associated with admission to the ICU. Two hundred eighty
(87%) children received oseltamivir, with no difference in rates of
administration between the ICU and the floor. After the Food and
Drug Administration (FDA) issued an Emergency Use Authoriza-
tion (EUA) for peramivir to treat 2009 H1N1 influenza virus on
October 23, 2009, four patients in the ICU received peramivir.
Thirty-eight (15%) of 247 patients tested by respiratory viral
PCR had another virus identified including entero/rhinovirus (31),
Table 1. Demographics and underlying medical conditions in children hospitalized with 2009 H1N1 influenza infection.
TOTAL FLOOR PICU p value
#
N=307 N=227 (74%) N=80 (26%)
DEMOGRAPHICS Number (%) Number (%) Number (%)
Male sex 186 (61)
+ 132 (58) 54 (68) 0.15
Hispanic/Latino 117 (38) 88 (39) 29 (36)
American Indian 4 (1) 3 (1) 1 (1)
Asian 4 (1) 3 (1) 1 (1)
Black 40 (13) 32 (14) 8 (10)
White 121 (39) 83 (37) 38 (48)
Unknown/Not reported 21 (7) 18 (8) 3 (4)
Age, years [median (IQR)] 6.0 (2.4–10.2) 5.7 (1.8–9.8) 6.7 (4.1–11.7) 0.02
^
Age Category
0–23 months 67 (22) 59 (26) 8 (10) , 0.001
++
2–4 years old 56 (18) 39 (17) 17 (21)
5–9 years old 104 (34) 74 (33) 30 (38)
10–17 years old 73 (24) 51 (22) 22 (28)
.18 years old 7 (2) 4 (2) 3 (4)
UNDERLYING MEDICAL CONDITIONS*
Any 203 (66) 146 (64) 57 (71) 0.28
Asthma 80 (26)
+ 63 (28) 17 (21) 0.16
Chronic lung disease 53 (17) 34 (15) 19 (24) 0.11
Cardiovascular disease 26 (8) 17 (7) 9 (11) 0.36
Renal disease 10 (3) 7 (3) 3 (4) 1
GI/liver disease 7 (2) 6 (3) 1 (1) 0.68
Oncologic 19 (6) 15 (7) 4 (5) 0.6
Hematologic disorder 9 (3) 8 (4) 1 (1) 0.45
Neurologic disorder (any) 74 (24) 44 (19) 30 (38) 0.002
seizure disorder 37 (12) 20 (9) 17 (21) 0.01
cerebral palsy 25 (8) 15 (7) 10 (13) 0.15
cognitive/developmental impairment 57 (19) 33 (15) 24 (30) 0.01
other neurologic disease 37 (12) 24 (11) 13 (16) 0.23
Immunocompromised 22 (7) 20 (9) 2 (3) 0.08
Prematurity 10 (3) 10 (4) 0 (0) 0.6
Obesity (BMI.95% for age)** 41/217 (19)
+ 31/152 (20) 10/65 (15) 0.45
Other 7 (2) 4 (2) 3 (4) 0.38
#Fisher’s exact test.
^Wilcoxon sum rank test.
*children may have more than one underlying condition.
**BMI calculated only for children .2 years of age.
+These conditions were significantly associated (p,0.05) with admission when compared with prevalence rates in Colorado (chi square statistic). Prevalence of asthma
and obesity in Colorado in 2008 were reported to be 10% and 13.6%, respectively.
++Chi square statistic for comparison of children less than 2 years of age to those 2 years of age and older.
doi:10.1371/journal.pone.0015173.t001
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entero/rhinovirus plus parainfluenza (2). Twenty-one patients had
a positive blood culture, 8 of which were considered contaminants.
Organisms considered true bacteremia included: Streptococcus
pneumoniae (3), methicillin-susceptible Staphylococccus aureus (MSSA)
(2), group A Streptococcus (1), Bacillus cereus (1), E. coli (1), Candida
species (2), Moraxella catarhalis (1) Staphylococcus epidermidis, (1) and
Streptococcus viridans (1). Of those with Streptococcus pneumoniae
bacteremia, one had a lobar pneumonia and one died of
meningitis shortly after admission. One patient with MSSA and
the patient with GAS bacteremia had positive pleural cultures with
these organisms also. Aspergillus flavus grew from a post mortem
lung culture from one patient who died of respiratory failure.
Multivaratiate logistic regression analysis identified four statis-
tically significant risk factors in hospitalized children associated
with admission to the ICU. These included older age (OR 1.07,
1.01–1.13, p=0.02), underlying neurological condition (OR 2.16,
1.16–4.01, p=0.02), hypoxia on admission (OR 2.9, 1.15–5.58,
p=0.002), and presenting with mental status changes (OR 12.54,
4.08–38.56, p,0.001).
Intensive Care Unit Course for 2009 H1N1
The clinical course of children with 2009 H1N1 influenza
admitted to the ICU are shown in Table 3. Reasons for admission
to the ICU included respiratory distress (81%), seizures and mental
status changes (19%), hypotension (19%), sepsis (4%) and other
(14%). Most patients admitted to the ICU required ventillatory
support, for the others, ICU services were required for either
hypotension or management of encephalopathy. Twenty four
(30%) of the ICU patients required hemodynamic support. Non
invasive ventilation was used in 26 patients (33%) and 32 (40%)
children were intubated with a median duration of 9 days. High
frequency oscillation was used in 10 patients (13%). Seventeen
(53%) of the 32 intubated patients developed acute respiratory
distress syndrome (ARDS). Extracorporeal membrane oxygena-
tion (ECMO) was used for 4 patients, with a median duration of 9
days. Eight patients died during their hospital course and one died
in the emergency room prior to admission to the hospital (Table 4).
The most common cause of death was respiratory failure. Two of
the children who died had no underlying medical conditions and
only one child who died was less than 2 years of age.
Comparison of 2009 H1N1 Influenza to 2008–09 Seasonal
Influenza
The clinical characteristics of hospitalized children with 2009
H1N1 compared to 2008–09 seasonal influenza are shown in
Table 3. There were a total of 90 patients admitted with 2008–09
seasonal influenza, 27 (30%) of which were admitted to the ICU.
Hospitalized children with 2009 H1N1 influenza were significantly
older, had a higher incidence of asthma, were more likely to
receive antiviral therapy, had a shorter median length of stay, and
had a higher incidence of ARDS compared to children
hospitalized with 2008–09 influenza (Table 3).
Discussion
We report the largest, single-center study of consecutively
hospitalized children with 2009 pandemic influenza A (H1N1)
virus infection in a tertiary care children’s hospital. Children less
than 2 years of age have been reported to be at highest risk for
hospitalization with seasonal and 2009 H1N1 influenza infec-
tions[7,8,9], and it has been assumed they would also be at highest
risk for admission to an intensive care unit. In support of this, a
recent pediatric study from Argentina, reported that children less
than 4 years were at highest risk for severe disease with 2009
H1N1 influenza infection [7]. In contrast to these reports,
however, our study is the first to demonstrate that older
hospitalized children with H1N1 were significantly more likely
to require intensive care services than hospitalized children less
than 2 years of age. The age group 4–5 years formed the largest
group with severe 2009 H1N1 infection requiring intensive care
services and the median age of hospitalized children was 6 years.
Figure 2. Number of children hospitalized with 2009 H1N1 influenza infection by age group.
doi:10.1371/journal.pone.0015173.g002
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infection.
TOTAL FLOOR PICU p value*
N=307 N=227 N=80
CLINICAL SYMPTOMS Number (%) Number (%) Number (%)
Day of illness admitted [median (IQR)] 3 (1–5) 3 (2–5) 3 (1–5) 0.46**
Day of fever admitted [median (IQR)] 2 (1–3) 2 (1–4) 1 (0–3) 0.2**
Fever 261 (85) 195 (86) 66 (83) 0.46
Duration [median (IQR)] 3 (2–6) 3 (2–6) 4 (2–6) 0.14**
Vomiting 107 (35) 78 (34) 29 (36) 0.79
Diarrhea 37 (12) 28 (12) 9 (11) 0.85
Shortness of breath/Increased work of breathing 172 (56) 120 (53) 52 (65) 0.07
Cough 254 (83) 194 (85) 60 (75) 0.02
Seizures 19 (6) 7 (3) 12 (15) ,0.001
Mental status changes 21 (7) 5 (2) 16 (20) ,0.001
PHYSICAL EXAM FINDINGS
Crackles 78 (25) 58 (26) 20 (25) 1
Wheezing 74 (24) 53 (23) 21 (26) 0.65
Hypoxia 193 (63) 132 (58) 61 (76) 0.007
Duration [median (IQR)] 3 (2–5) 2 (1–3) 6 (3–14) ,0.001**
Tachypnea 164 (53) 115 (51) 49 (61) 0.15
Decreased breath sounds 105 (34) 67 (30) 38 (48) 0.006
ADMISSION LABS
WBC #4( 1 0
3/uL) 37/177 (21) 28/107 (26) 9/70 (13) 0.04
WBC $12 (10
3/uL) 31/177 (18) 16/107 (15) 15/70 (21) 0.31
platelet #150 (10
3/uL) 43/175 (25) 23/107 (21) 20/70 (29) 0.37
platelet $500 (10
3/uL) 4/175 (2) 2/105 (2) 2/70 (3) 1
Creatinine (mg/dL) 8/135 (6) 2/70 (3) 6/65 (9) 0.15
AST $180 (U/L) 8/71 (11) 3/37 (8) 5/34 (15) 0.47
ALT $120 (U/L) 8/72 (11) 2/37 (5) 6/35 (17) 0.15
elevated LFTs (AST or ALT $36normal) 9/72 (13) 3/37 (8) 6/35 (17) 0.3
bilirubin $0.9 (mg/dL) 4/38 (6) 3/35 (9) 1/33 (3) 0.61
albumin ,3.1 (g/dL) 21/74 (28) 6/37 (16) 15/37 (41) 0.04
CRP $1 (mg/dL) 52/76 (68) 24/42 (57) 28/34 (82) 0.03
CRP .10 (mg/dL) 17/76 (22) 7/42 (17) 10/34 (29) 0.27
median CRP (IQR) (mg/dL) 2.2 1.3 4.1 0.004
acidotic (blood pH ,7.35) 51/78 (65) 4/15 (27) 47/63 (75) 0.002
MEDICATIONS
Oseltamivir 269 (88) 195 (86) 74 (93) 0.11
10 day course or longer 29 (9) 3 (1) 26 (33) ,0.001
Time from start of fever to oseltamivir [median (IQR)] 2 (1–4) 2 (1–4) 1 (0–3) 0.11**
Time from admission to oseltamivir [median (IQR)] 0 (0–1) 0 (0–1) 0 (0–1) 0.37**
Antibioitics 201 (65) 136 (60) 65 (81) ,0.001
Steroids 110 (36) 74 (33) 36 (45) 0.06
Bronchodilators 136 (44) 95 (42) 41 (51) 0.15
Length of stay [median (IQR)] 3 (2–6) 2 (2–4) 6 (3–17) ,0.001**
*Fisher’s exact test.
**Wilcoxon sum rank test.
doi:10.1371/journal.pone.0015173.t002
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where the median patient age was 1.8 years, and the median age of
patients admitted to the PICU was 2.2 years.
The reasons for the peak age differences in disease severity for
2009 H1N1 are unclear. One possible explanation is that younger
children may have a less robust immune response to 2009 H1N1
and, therefore, not develop severe pulmonary disease which may
be immune mediated. This would imply that the 2009 H1N1 virus
elicits a different or more robust immune response than seasonal
influenza. It is possible that the youngest children were thought to
be at highest risk for severe disease and were targeted for earlier
and more aggressive treatment which may have altered the course
of their illness. Our study, however, does not support this
hypothesis as almost 85% of children, both less than 2 years and
greater than 2 years age, received oseltamivir within 24 hours of
admission and there were no differences from time of onset of
illness to admission between these two groups. Alternatively, in our
community, the epidemic peak occurred approximately 6 weeks
after the annual reopening of schools (start date for Denver public
schools was August 19) which could have resulted in a larger
number of older, school-aged children being exposed resulting in a
larger number being infected with 2009 H1N1, some of whom
developed severe infection.
Our study found that having an underlying neurologic disorder
was a risk factor for admission to the ICU with 2009 H1N1.
Interestingly, half of the patients in the intensive care unit who had
underlying neurologic disorders did not have any associated
neuromuscular or pulmonary disorders such as asthma, chronic
aspiration, or recurrent pneumonia. These findings support and
strengthen the recommendations that this group of patients with
2009 H1N1 infection need to be aggressively targeted for
immunization, prophylaxis, early recognition, and prompt
treatment.
Viral co-infections and secondary bacterial infections were
infrequent in our H1N1 cohort. The low incidence of other
respiratory viruses may be explained by the fact that our peak of
illness occurred in the early fall before our winter respiratory viral
season. Although the majority of children with H1N1 admitted to
Table 3. Comparison of selective characteristics of hospitalized children with 2009 pandemic H1N1 influenza A versus 2009–10
seasonal influenza.
2009 H1N1 Pandemic (swine) Influenza A 2008–09 Seasonal Influenza A or B p value*
N=307 N=89
Male Sex 186 (61%) 47 (53%) 0.22
Median Age, years [median (IQR)] 6.0 (2.4–10.2) 1.8 (0.7–8.5) ,0.0001
#
Length of Stay, days [median (IQR)] 3 (2–6) 4 (2–8) 0.02
#
Fever 261 (85%) 74 (83%) 0.74
Hypoxia 193 (63%) 59 (67%) 0.62
Vomitting 107 (35%) 25 (28%) 0.25
Diarrhea 37 (12%) 4 (4%) 0.047
Seizures 19 (6%) 8 (9%) 0.47
Mental Status Changes 21 (7%) 10 (11%) 0.18
Any Underlying Medical Condition 203 (66%) 46 (52%) 0.64
Asthma 80 (26%) 12 (13%) 0.02
Chronic lung disease 53 (17%) 16 (18%) 0.49
Any neurological condition 74 (24%) 25 (28%) 0.49
seizure disorder 37 (12%) 9 (10%) 0.71
cerebral palsy 25 (8%) 7 (8%) 1
cognitive/development impairment 57 (19%) 21 (24%) 0.36
other neurological condition 37 (12%) 17 (19%) 0.11
CRP [median (IQR)] 2.2 2.8 (0.6–6.6) 0.92
#
Received Antiviral Therapy 269 (88%) 28 (31%) ,0.0001
Admit to ICU 80 (26%) 27 (30%) 0.5
Characteristic of Patients Admitted to the ICU
N=80 N=27
Intubated 32 (40%) 14 (52%) 0.4
High frequency oscillator 10 (13%) 1 (4%) 0.28
ARDS 17 (21%) 1 (4%) 0.04
ECMO 4 (5%) 1 (4%) 1
New Disability 14 (18%) 5 (19%) 1
Death 9 (11%) 2 (7%) 0.73
*Fisher’s exact test.
#Wilcoxon rank sum test.
doi:10.1371/journal.pone.0015173.t003
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presented with or developed any clinical or laboratory evidence of
secondary bacterial infections.
In our study, 26% of the hospitalized children with 2009 H1N1
were admitted to the ICU. Although our ICU admission rates
were not different between 2009 H1N1 and 2008–09 seasonal
influenza, it is in contrast to the 2003–04 influenza season, the
most recent severe influenza epidemic in the United States, where
a multi-state study reported 11% of hospitalizations in children
resulted in ICU admission [10]. The increased use of ICU services
associated with children with 2009 H1N1 infection was also
supported by a recent study in Atlanta which showed an increase
in the proportion of ICU admission for children presenting to the
emergency department with influenza-like illness compared with
two previous influenza seasons [11].
More than half of the intubated children with H1N1 in our
study developed ARDS compared to 7% of seasonal influenza
patients. Additionally, there was a trend toward higher use of
high frequency ventilation compared to the previous season.
This is in contrast to the pediatric study from Argentina where
only 17% of the ICU admissions required mechanical ventila-
tion[7], but similar to a children’s case series from Johns Hopkins
in which 46% required mechanical ventilation [12]. We
speculate that the high incidence of ARDS in school age
children may be related to an excessive immune response
mediated by cytokines to this novel strain of influenza. Further
studies are needed to determine whether particular virulence
factors unique to the 2009 pandemic influenza A (H1N1) virus
strain or host response to the virus explains this high severity of
pulmonary dysfunction.
Interestingly, our study showed a longer hospitalization among
children admitted with 2008–09 seasonal influenza compared to
children hospitalized with 2009 H1N1. This may be explained by
a significantly lower rate of receipt of antiviral therapy in
hospitalized children with seasonal influenza compared with
2009 H1N1 influenza. For 2009 H1N1, the hospital adopted a
recommendation to initiate antiviral therapy on any hospitalized
patient with influenza, compared to the prior influenza season,
when patients were only started on antiviral medication if they
presented in the first 48 hours of symptoms or if they were severely
ill.
There are several limitations of our study. Our hospital is the
only academic tertiary children’s hospital in the state of Colorado
and serves as a referral center for neighboring states, which might
explain our higher admissions to the ICU. Second, for 2009 H1N1
there were fifty-one patients included in our study that had a
positive influenza IA, but did not have enough sample left for
confirmatory PCR. Therefore, we may have included a very small
number of patients who had a falsely positive influenza IA test.
Based on our laboratory’s experience with other specimens,
however, we estimate that at most we may have had 9 false
positives, 3% of our total study population. Additionally, we
performed a subanalysis on the patients who were only PCR
positive, which did not alter any of our findings. Third, although
PCR testing was implemented during the 2008–09 season, a lower
percentage of samples had confirmatory PCR testing performed.
Finally, this study looked only at hospitalized children and
therefore does not reflect the full spectrum of disease caused by
H1N1 as seen in the community.
In summary, in 2009 H1N1 hospitalized children, older age and
having an underlying neurological medical condition were
significant independent risk factors for development of severe
disease. In general, hospitalized children with H1N1 who were
admitted to the ICU had a severe disease course, as evidenced by
the high use of oscillatory ventilation and a high incidence of
ARDS. The comparison to seasonal influenza highlights the
difference in age groups hospitalized with H1N1 and the increased
severity of pulmonary disease. These observations identify new
high risk groups of children who might benefit from increased
emphasis on prevention, earlier recognition, and new treatment
strategies for H1N1 infections.
Acknowledgments
We thank Suhong Tong for statistical support. We particularly thank our
colleagues in epidemiology, Susan Dolan, Roberta Smith, and Ann-
Christine Nyquist, and in the clinical laboratory, Elaine Dowell and
Christine Robinson, who worked tirelessly during this epidemic.
Table 4. Summary of patients who died secondary to 2009 pandemic influenza A (H1N1) infection.
Sex Age Underlying medical condition Cause of death
Time to death
from start of
illness
Time of death from
admission to the
hospital
Received
Oseltamivir
M 18 yrs Dravet’s syndrome, developmental delay Respiratory failure 4 days 2 days Yes
M 12 yrs Chromosome 11 mutation Tourette
syndrome, asthma, esophageal strictures
Esophageal anastamosis leak, septic
shock, ARDS, acute renal failure
5 days 64 days* No
F 11 yrs Hypothalamic hamartoma,
hydrocephalus, seizure disorder,
precocious puberty, diabetes insipidus
Respiratory failure 17 days 12 days Yes
M 8 yrs Craniopharyngioma, spastic
quadriplegia, asthma
Respiratory failure 5 days 3 days Yes
M 4 yrs Seizure disorder Respiratory failure 30 days 28 days Yes
F 2 yrs None Cardiovascular failure 3 day 1 days Yes
M 9 months Hypotonia and developmental delay Cerebral edema secondary to
pneumococcal meningitis
12 days 3 days Yes
F 12 yrs New diagnosis of T cell leukemia
with this infection
Septic shock/respiratory failure with
Aspergillus flavus lung infection
27 days 20 days Yes
F 7 yrs None Cardiopulmonary arrest 2 days Died in ER No
*infection nosocomially acquired.
doi:10.1371/journal.pone.0015173.t004
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